Company intelligence / Profile preview

CMO Consulting

Concord, MA, USA

Ownership: Private
Employees: ~5
Development stage: Other

Overview

CMO Consulting is a specialized clinical drug development consultancy focused on medical oncology. Led by Dr. Edward Garmey, the firm provides strategic leadership and executional support to biopharmaceutical companies, ranging from startups to established entities. Their services span the drug development lifecycle, including pre-IND optimization, biomarker strategy, clinical trial design (Phase 1-3), and regulatory filings. The team leverages extensive academic and industry experience to help clients build clinical infrastructure and navigate complex registration pathways.

Therapeutic areas: OncologyHematology
Modalities: Small moleculeMonoclonal antibodyVaccinePeptide-drug conjugateCell therapy
Industry: Consulting

Partnerships

Sensei BiotherapeuticsGenocea BiosciencesBicycle TherapeuticsImmuneSensor

Beyond the preview

Go deeper on CMO Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMO Consulting.

Explore the full profile